Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer
Giannis Mountzios(Henry Dunant Hospital), Petros Christopoulos(Heidelberg University), Katharina Kriegsmann(Heidelberg University), Rami A. El Shafie(University Hospital Heidelberg), Ioannis Boukovinas, Johannes Krisam(University Hospital Heidelberg), Sofia Baka(Interbalkan Medical Center), George Pentheroudakis(University of Ioannina), Sofia Agelaki(University of Crete), C. Andreadis(Theageneio General Hospital), Felix Herth(Heidelberg University), Farastuk Bozorgmehr(Heidelberg University), Albrecht Stenzinger(Heidelberg University), G. Oikonomopoulos(Metropolitan Hospital), Εleftherios Ζervas(Sotiria General Hospital), Zenia Saridaki, Michael Meister(German Center for Lung Research), C. Emmanouilides(Interbalkan Medical Center), Ilias Athanasiadis(Mitera Hospital), Martin Reck(LungenClinic Grosshansdorf), Epaminontas Samantas(Metropolitan Hospital), Evangelos Lianos(Metaxa Hospital), H. Winter(German Center for Lung Research), Helge Bischoff(Heidelberg University), Mariam Elshiaty(University Hospital Heidelberg), Amanda Psyrri(University General Hospital Attikon), Athina Christopoulou(Agios Andreas Hospital), Claus Peter Heußel(Heidelberg University), Lena Gaissmaier(National Center for Tumor Diseases), Mark Kriegsmann(Heidelberg University), Κonstantinos Samitas, Εleni-Isidora Perdikouri(Agios Pavlos General Hospital), Jonas Kuon(Heidelberg University), Thomas Muley(German Center for Lung Research), Elena Fountzilas(European University Cyprus), Evangelia Razis(Hygeia Hospital), Michael Thomas, P. Kosmidis(Hygeia Hospital), L Daniello(University Hospital Heidelberg), Helena Linardou(Metropolitan Hospital), K. Syrigos(Sotiria General Hospital), K. Senghas(National Center for Tumor Diseases)
Cited by 93
Related Papers
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer
|New England Journal of Medicine|2013|3.4k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|2.3k